… than heparin monotherapy for STEMI patients undergoing primary PCI [… safety and
effectiveness of bivalirudin plus post-PCI infusion in comparison to heparin alone for STEMI patients …

… The relative safety and efficacy of heparin and bivalirudin needed to be assessed in a
study design representing modern PPCI practice. Our trial, How Effective are Antithrombotic …

… (66%) received UFH and 1,139 (34%) received bivalirudin. … In a propensity-score matched
analysis, bivalirudin-based … a real-world cohort of patients undergoing PCI, bivalirudin-based …

… bivalirudin from hirudin is the reversibility of the bivalirudin:… in 88% of patients and 24% of
bivalirudintreated patients also … Patients treated with bivalirudin had a lower incidence of death, …

… , have been overcome through development of the hirudin analogue, bivalirudin.
Compared with hirudin derivatives, bivalirudin exhibits a shorter half-life (25 vs 80 minutes), …

… To evaluate the efficacy of intraoperative application of 80% bivalirudin, patients with ACS
were included in this study. In the BRIGHT study (24), the recommended dose infusion was …

… use of bivalirudin as post-PCI anticoagulant strategy was associated with a decrease in the
bleeding risk, and thus, it may be an efficient bleeding avoidance strategy in elderly patients …

… The proportion of elderly patients undergoing primary … Notably, bivalirudin was not a
predictor of stent thrombosis or … recommendations for these patients, bivalirudin use would a …

… This study sought to assess the safety and the efficacy of bivalirudin compared with unfractionated
heparin (UFH) alone in the subset of patients at increased risk of bleeding undergoing …

… the bivalirudin anticoagulant effect from the placebo effect. The bivalirudin treatment group
… The selection of doses was based on the instructions for bivalirudin use marketed in the …